Price
CHART BY
Frequently asked questions
What is Biote's market capitalization?
The market capitalization of Biote is $199.47M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Biote's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Biote is 30.06. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Biote?
Biote's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $0.203. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Biote's stock?
Currently, 6 analysts cover Biote's stock, with a consensus target price of $9.873. Analyst ratings provide insights into the stock's expected performance.
What is Biote's revenue over the trailing twelve months?
Over the trailing twelve months, Biote reported a revenue of $193.06M.
What is the EBITDA for Biote?
Biote's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $44.02M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Biote?
Biote has a free cash flow of $35.23M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Biote have, and what sector and industry does it belong to?
Biote employs approximately 194 people. It operates in the Health Care sector, specifically within the Hospital/Nursing Management industry.
What is the free float of Biote's shares?
The free float of Biote is 30.04M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $199.47M
- EPS (TTM)
- $0.203
- Free Float
- 30.04M
- P/E ratio (TTM)
- 30.06
- Revenue (TTM)
- $193.06M
- EBITDA (TTM)
- $44.02M
- Free Cashflow (TTM)
- $35.23M
Pricing
- 52W span
- $3.69$8.44
Analyst Ratings
The price target is $9.873 and the stock is covered by 6 analysts.
Buy
6
Hold
0
Sell
0
Information
biote Corp. is a woman-led company, which engages in providing bio identical hormone pellet therapy. It delivers a comprehensive, end-to-end platform that provides practitioners with medical education, training and certification, practice management software, and digital and point-of-care marketing support. The company was founded in 2012 and is headquartered in Irving, TX.
- Employees
- 194
- Industries
- Hospital/Nursing Management
- Sector
- Health Care
Identifier
- ISIN
- US0906831039
- Primary Ticker
- BTMD